These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21119030)

  • 1. Compliance with Good Clinical Practice in oncology registration trials in Japan.
    Yonemori K; Hirakawa A; Ando M; Hirata T; Shimizu C; Katsumata N; Tamura K; Fujiwara Y
    Ann Oncol; 2011 Jun; 22(6):1451-1456. PubMed ID: 21119030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A descriptive research: Exclusion from submitted clinical data package in the review process of new drug approval due to GCP violation in Japan.
    Asada R; Yoshimura K; Hattori K; Nonaka Y; Kasai H; Shimizu S
    Contemp Clin Trials Commun; 2019 Sep; 15():100416. PubMed ID: 31406948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Performing clinical trials efficiently in Japan--independent clinical trials and GCP].
    Kanai M; Suzuki-Nishimura T
    Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):449-54. PubMed ID: 17644939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quality of conduct in Japanese clinical trials: deficiencies found in GCP inspections.
    Ono S; Kodama Y; Nagao T; Toyoshima S
    Control Clin Trials; 2002 Feb; 23(1):29-41. PubMed ID: 11852162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of Japanese clinical trials estimated from GCP audit findings.
    Saito K; Kodama Y; Ono S; Maida C; Fujimura A; Miyamoto E
    Int J Clin Pharmacol Ther; 2008 Aug; 46(8):415-20. PubMed ID: 18793583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs.
    Hata T; Nakamura K; Yonemori K; Noguchi E; Watanabe M; Sohn J; Lu YS; Yap YS; Tamura K; Fujiwara Y
    Clin Transl Sci; 2021 May; 14(3):1015-1025. PubMed ID: 33382914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of clinical trials by Ethics Committees in Germany--results and a comparison of two surveys performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Russ H; Busta S; Jost B; Bethke TD
    Ger Med Sci; 2015; 13():Doc02. PubMed ID: 25698912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In order to perform clinical trials efficiently in Japan--important issues in medical institutions raised by the GCP on-site review].
    Akiyama T; Furuta M; Yamada H
    Nihon Kokyuki Gakkai Zasshi; 2006 Aug; 44(8):541-9. PubMed ID: 16972610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of elderly patients in registration trials for oncology drug applications in Japan.
    Yonemori K; Hirakawa A; Komiyama N; Kouno T; Ando M; Fujiwara Y; Urano T; Akagawa H; Maruyama H; Toyoshima S
    Ann Oncol; 2010 Oct; 21(10):2112-2118. PubMed ID: 20332138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent changes in quality in Japanese clinical trials.
    Saito K; Kodama Y; Ono S; Fujimura A
    Ann Pharmacother; 2004 Jan; 38(1):151-5. PubMed ID: 14742810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of quality in Japanese clinical trials.
    Saito K; Kodama Y; Ono S; Mutoh M; Kawashima S; Fujimura A
    Contemp Clin Trials; 2005 Aug; 26(4):503-9. PubMed ID: 16054582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoting good clinical practices in the conduct of clinical trials: experiences in the Department of Veterans Affairs Cooperative Studies Program.
    Sather MR; Raisch DW; Haakenson CM; Buckelew JM; Feussner JR;
    Control Clin Trials; 2003 Oct; 24(5):570-84. PubMed ID: 14500054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
    Ebi O
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of protocol deviations in Japanese oncology registration trials: a single institute experience.
    Sasada S; Ushirozawa N; Kobayashi N; Fujiwara Y; Tamura K; Yamamoto N
    Invest New Drugs; 2017 Jun; 35(3):392-396. PubMed ID: 28150072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of clinical development and regulatory submission promotion schemes for oncologic drugs as the Japanese national projects.
    Nagai S; Ozawa K
    Invest New Drugs; 2016 Dec; 34(6):777-791. PubMed ID: 27538583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current problems of early phase clinical trials for new anticancer agents in Japan].
    Nakagawa K; Fukuoka M
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):925-9. PubMed ID: 10897223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability and profile of the clinical drug trials underway in Finnish university hospitals in the 1990s: applications reviewed by ethics committees.
    Keinonen T; Nieminen S; Saareks V; Saano V; Ylitalo P
    Methods Find Exp Clin Pharmacol; 2001 Sep; 23(7):415-23. PubMed ID: 11771857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Descriptive Analysis of Good Clinical Practice Inspection Findings from U.S. Food and Drug Administration and European Medicines Agency.
    Sellers JW; Mihaescu CM; Ayalew K; Kronstein PD; Yu B; Ning YM; Rodriguez M; Williams L; Khin NA
    Ther Innov Regul Sci; 2022 Sep; 56(5):753-764. PubMed ID: 35610469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.